Sildenafil. Tadalafil. Avanafil. That's the list every telehealth quiz hands you.
The 4th molecule, vardenafil, isn't on the menu. Not because it doesn't work — because the company that owned the brand walked away from it in 2021, and the global pharma giants didn't pick up the manufacturing slack.
Which means if sildenafil failed you, the option that has a 49% rescue rate in trial data is the one nobody's selling you.
The molecule the boardroom killed.
Vardenafil hit the US market in 2003 under the brand Levitra. Bayer + GSK + Schering-Plough launched it as the second-to-market PDE5 inhibitor (the enzyme that holds blood-vessel signals open in the corpus cavernosum), one year after sildenafil and a few months ahead of tadalafil.
GSK returned its share of the rights to Bayer in 2010. Then in 2021, Bayer discontinued the US Levitra brand entirely. The ANDA-approved generic exists, but US generic uptake was thin. Most chain pharmacies don't stock it. Most telehealth platforms don't list it.
It didn't lose on chemistry. It lost on shelf space.
The 49% rescue rate nobody quotes.
Carson and colleagues ran the PROVEN trial in 2004 (BJU Int, PMID 15610110). 463 men who had failed on sildenafil — defined as inability to achieve satisfactory erection at full dose — were given vardenafil 5/10/20mg over 12 weeks.
The numbers from that trial:
- Successful intercourse went from 10.5% at baseline → 46.1% on vardenafil (vs ~10% on placebo)
- 61.8% reported improved erections vs 14.7% on placebo
- 30% reached IIEF-EF ≥ 26 (the threshold for "no ED") vs 6% on placebo
Half of the men who had been written off as PDE5 non-responders responded to a different PDE5 inhibitor. That's the highest-evidence rescue data published for any of the four molecules. And it's almost never quoted, because the brand that funded the trial doesn't sell the pill in the US anymore.
Vardenafil is the way Betamax was — the better tape that lost the marketing war. Still plays just fine when you find a deck.
Vardenafil isn't a sildenafil clone.
The four PDE5 inhibitors look identical at a press-release level. They're not.
Half-life ~4-5 hours. Closer to sildenafil (~4h) than tadalafil (~17.5h). Vardenafil is a "take it before sex" pill, not a daily pill.
Onset 25-60 minutes (Tmax ~50 min on empty stomach, Goldstein 2003 J Urol). Slightly faster than sildenafil for many users, slower than avanafil.
PDE6 selectivity better than sildenafil. PDE6 lives in your retina. Sildenafil's weak hit on PDE6 is what causes the famous "blue tinge" / chromatopsia in roughly 3-11% of users at high doses. Vardenafil's PDE5/PDE6 ratio is more selective (Wang 2012, BJU Int) — visual side effects are markedly less frequent in trial data.
CYP3A4 metabolism. Same as sildenafil and tadalafil. Same grapefruit warning. Same interaction with strong CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin).
Mild QT prolongation flag. Vardenafil's label carries a thorough QT-study language sildenafil and tadalafil don't. Practical translation: if you're already on a QT-prolonging drug or have known long-QT syndrome, vardenafil isn't your first pick.
Less food-sensitive than sildenafil. Sildenafil loses ~29% Cmax with a fatty meal (Goldstein 1998 NEJM). Vardenafil's drop is smaller. If you eat a steak before sex, vardenafil holds up better than sildenafil — though tadalafil is the most food-indifferent of the four.
Why no global generic giant makes vardenafil at scale.
Here's the supply-chain reality most people don't know: the multi-vertical generic giants — Cipla, Sun Pharma, Dr. Reddy's, Lupin — don't have vardenafil ANDAs in active large-scale production. They have sildenafil. They have tadalafil. Vardenafil's third-line market is small, and these companies allocate ANDA portfolio bandwidth to HIV, oncology, and cardiovascular generics first.
The vardenafil supply that does exist comes from ED-export specialists: Sunrise Remedies (Zhewitra) and Ajanta Pharma (Valif). Same WHO-GMP facility standards Cipla and Sun operate under for their sildenafil and tadalafil lines. Smaller global distribution networks. Less brand redundancy than sildenafil — where you can pick from a dozen Cipla / Sun / Dr. Reddy's lines, but vardenafil hands you two solid options instead of twelve.
This is why vardenafil looks "obscure." Not because it's unsafe. Because the boardroom didn't see enough margin to keep it in the US retail catalog.
When vardenafil beats sildenafil and tadalafil.
Vardenafil is not a first-line PDE5. It's a third-line one. The decision tree:
Sildenafil 100mg failed twice at adequate dose with proper timing (60 min before, empty stomach, sufficient sexual stimulation). Don't escalate to 150mg — the dose-response curve flattens. Switch molecule.
Try tadalafil first. It's the most-different mechanism (long half-life, daily-dose option) and Carson-style rescue data exists for tadalafil-after-sildenafil failure too.
Tadalafil also failed (PRN at 20mg or 5mg daily for 4 weeks). Now vardenafil is the evidence-based next move. PROVEN trial: 49% rescue.
You're getting the blue tinge from sildenafil. Vardenafil's better PDE6 selectivity is the direct fix.
Food timing keeps wrecking sildenafil for you. Vardenafil holds up better than sildenafil with food.
(Tadalafil holds up best of the four — that's the upgrade if food is your only issue.)
You're a first-time PDE5 user. Don't start here. Sildenafil 50mg is the FDA-recommended starting dose, and 80%+ of men respond. The first-line evidence base is enormous. Save vardenafil for when you actually need a different molecule.
Both sildenafil AND tadalafil AND vardenafil all failed at adequate dose with two real attempts each. This is when you stop refilling pills and book a urologist. Not for a higher dose. For a workup — vascular, hormonal, or something else is going on, and a 4th-line PDE5 escalation isn't the answer.
Pricing — the molecule, not the brand.
The brand was always the problem. Strip it out and the math gets clean.
- US Levitra brand (discontinued 2021): $89-149/pill at peak, before Bayer pulled it
- US generic vardenafil 20mg, CVS + GoodRx 2025: ~$30-50 for 30 tablets (when stocked)
- LiberaCure-routed generic vardenafil 20mg: ~$0.50-0.85/pill, $15-25 for 30 tablets
$89 brand pill vs $0.50 same-molecule generic — same WHO-GMP factory floor as Cipla's sildenafil. Most of that gap is brand premium, not molecule cost.
For reference on operational shape: 2-week standard shipping from a licensed Indian pharmacy, 2-4 weeks with customs variance. Customs hold typically resolves in 5-10 extra days; if you need pills this week, this isn't the route. Tracking goes active 24-48h after dispatch. Crypto-only checkout — payment processors that handle personal-import either charge premium fees or cut sites off mid-cycle, so the markup tier here is partly a choice to skip card-network fees.
If your package doesn't arrive, we reship free. Twice. Crypto refund (BTC/ETH/USDT) on the third failure. Email reply within 48h at [email protected] — no live chat, no phone. Crypto means no chargeback, so this explicit reship-then-refund is the dispute path, not buried in a PDF.
What to do.
If you've already been through sildenafil 100mg twice with proper timing and it didn't work, before you order anything:
- Confirm the timing was right (60 min before, empty or near-empty stomach, real sexual stimulation, no nitrates / heavy alcohol)
- Try tadalafil next, not vardenafil. Different half-life, different practical pattern, strong evidence
- If tadalafil also fails over a real attempt window, then vardenafil 20mg PRN is the evidence-based next step
- Avoid grapefruit, all nitrates, and use caution with alpha-blockers (start lower if on tamsulosin / doxazosin)
- Two failed molecules at adequate dose with proper attempts → urology referral. Not a 4th pill.
Don't skip the order. Sildenafil → tadalafil → vardenafil. The PROVEN data is on second-switch responders, not on people who jumped molecules randomly.
A note on bias.
We route vardenafil orders. Be aware of that.
LiberaCure routes orders to licensed personal-import pharmacies. Our vardenafil line sources through ED-specialist firms — Zhewitra (Sunrise Remedies) and Valif (Ajanta) — same WHO-GMP standard the global pharma giants run their sildenafil on. The giants — Cipla, Sun Pharma, Dr. Reddy's, Lupin — don't have vardenafil in active ANDA production at the scale they hold sildenafil and tadalafil. Vardenafil's third-line market is smaller, and multi-vertical generic giants chase HIV / oncology / cardiovascular ANDAs first. So we have a financial reason to want this article to land on "give vardenafil a try if sildenafil failed."
Read this with that in mind. The protocol above — try tadalafil first if sildenafil failed, vardenafil third — is what I'd tell a friend, not what maximizes reorder rate.
Sources:
- Carson CC et al. The efficacy and safety of vardenafil in men with erectile dysfunction who did not respond to previous PDE5 inhibitor treatment. BJU Int 2004 (PROVEN trial). PMID 15610110
- Goldstein I et al. Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes. J Urol 2003. PMID 12771756
- Wang R et al. Selectivity of avanafil, a PDE5 inhibitor for the treatment of erectile dysfunction. BJU Int 2012. PMID 22591080
- Yuan J et al. Comparative effectiveness and safety of oral PDE5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol 2013;63(5):902-12.
- Goldstein I et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998;338:1397-1404.
- FDA Levitra label, NDA 21-400 (current revision through Bayer 2021 discontinuation notice).
- AllDayChemist Valif / vardenafil pricing snapshot, April 2026.
- LiberaCure catalog audit, 2026-04.
Related reading:
- The complete ED pillar guide: sildenafil, tadalafil, vardenafil, avanafil
- PDE5 inhibitors: 4 options, 4 half-lives, when to pick which
- Sildenafil 50mg vs 100mg: the dose telehealth doesn't tell you about
- Two ED pharmacies, same supplier, $30 vs $5 — what you're really paying for
- The 6 sildenafil brands worth knowing, ranked by manufacturer reliability
— LiberaCure editorial. We route generic medication through licensed personal-import pharmacies. We don't dispense, prescribe, or warehouse. Read more about why.